By Hector M. Samper, principal and strategic advisor, Global Strategic Sourcing Solutions (GSSS)
Off-site construction and modularization hold tremendous potential to drive agility and speed-to-market, but pharma and biotech companies need to thoroughly understand the modular process to evaluate its merits and develop an early execution plan.
Well-designed and high-performing patient registries are powerful tools that can strengthen the clinical case for a therapy and bolster patient engagement, helping companies to overcome the challenges facing novel therapies in the cell and gene space.
Pioneers in continuous biomanufacturing ponder which companies will incorporate continuous manufacturing first — and which “hot-button” implementation questions still require attention and clarification.
The stirred-tank reactor is the most commonly utilized in biotechnology. Learn more about the HyPerforma Single-Use Bioreactor (SUB), a stirred-tank reactor for animal cell culture with the advantage of utilizing completely single-use product contact surfaces.
Single-use bioreactors are increasingly used to perform mammalian cell cultures in commercial manufacturing applications. Learn how they address key industry challenges by decreasing time-to-market, reducing validation efforts, increasing flexibility, reducing investment costs, and optimizing cost of goods.
Explore the economic benefits of using a cell culture medium designed specifically for perfusion processes and the proactive risk measures suppliers need to take to facilitate the manufacturer’s business continuity and product quality.